Piezoelectric transducer

Information

  • Patent Grant
  • 7948148
  • Patent Number
    7,948,148
  • Date Filed
    Tuesday, October 13, 2009
    14 years ago
  • Date Issued
    Tuesday, May 24, 2011
    13 years ago
Abstract
A miniature piezoelectric transducer element is provided, comprising; (a) a cell element having a cavity; (b) a flexible piezoelectric layer attached to the cell member, the piezoelectric layer having an external surface and an internal surface, the piezoelectric layer featuring such dimensions so as to enable fluctuations thereof at its resonance frequency upon impinging of an external acoustic wave; and (c) a first electrode attached to the external surface and a second electrode attached to the internal surface of the piezoelectric layer. At least one of the electrodes may be specifically shaped so as to provide a maximal electrical output, wherein the electrical output may be current, voltage or power. A preferred shape of the electrodes includes two cores interconnected by a connecting member. The transducer element may function as a transmitter.
Description
FIELD AND BACKGROUND OF THE INVENTION

The present invention relates to a device for intrabody delivery of molecules, to a method and system of utilizing same and to a method of fabricating same. More particularly, embodiments of the present invention relate to a drug delivery device which utilizes an acoustic transducer for generating an electrical activation signal from an acoustic signal received thereby.


The efficacy of drug treatment is oftentimes dependent upon the mode of drug delivery.


Localized drug delivery is oftentimes preferred since it traverses limitations associated with systemic drug delivery including rapid drug inactivation and/or ineffectual drug concentrations at the site of treatment. In addition, in some cases, systemic drug delivery can lead to undesired cytotoxic effects at tissue regions other than that to be treated.


Since localized intrabody delivery of medication is central to efficient medical treatment, attempts have been made to design and fabricate intrabody delivery devices which are capable of controlled and localized release of a wide variety of molecules including, but not limited to, drugs and other therapeutics.


Controlled release polymeric devices have been designed to provide drug release over a period of time via diffusion of the drug out of the polymer and/or degradation of the polymer over the desired time period following administration to the patient. Although these devices enable localized drug delivery, their relatively simple design is limited in that it does not enable accurate and controlled delivery of the drug.


U.S. Pat. No. 5,490,962 to Cima, et al. discloses the use of three dimensional printing methods to make more complex devices which provide release over a desired time frame, of one or more drugs. Although the general procedure for making a complex device is described, specific designs are not detailed.


U.S. Pat. No. 4,003,379 to Ellinwood describes an implantable electromechanically driven device that includes a flexible retractable walled container, which receives medication from a storage area via an inlet and then dispenses the medication into the body via an outlet.


U.S. Pat. Nos. 4,146,029 and 3,692,027 to Ellinwood disclose self-powered medication systems that have programmable miniaturized dispensing means.


U.S. Pat. No. 4,360,019 to Jassawalla discloses an implantable infusion device that includes an actuating means for delivery of the drug through a catheter. The actuating means includes a solenoid driven miniature pump.


Since such devices include miniature power-driven mechanical parts which are required to operate in the body, i.e., they must retract, dispense, or pump, they are complicated and subject to frequent breakdowns. Moreover, due to complexity and size restrictions, they are unsuitable for delivery of more than a few drugs or drug mixtures at a time.


U.S. Pat. Nos. 6,123,861 and 5,797,898 both to Santini, Jr., et al. disclose microchip devices which control both the rate and time of release of multiple chemical substances either in a continuous or a pulsatile manner. Such microchip devices employ a reservoir cap which is fabricated of a material that either degrades or allows the molecules to diffuse passively out of the reservoir over time or materials that oxidize and dissolve upon application of an electric potential. Release from the microchip device can be controlled by a preprogrammed microprocessor, via a radiofrequency (RF) activation signal, or by biosensors.


Although the microchip device described by Santini, Jr., et al. presents substantial improvements over other prior art devices, it suffers from several inherent limitations which will be described in detail hereinbelow.


There is thus a widely recognized need for, and it would be highly advantageous to have, a delivery device and methods of fabricating and utilizing same which device can be used for accurate and timely delivery of a drug or drugs within a body tissue region devoid of the above limitation.


The present invention also relates to an acoustic transducer and, in particular, to a miniature flexural piezoelectric transducer for receiving acoustic energy transmitted from a remote source and converting such energy into electrical power for activating an electronic circuit. Further, the present invention relates to a miniature flexural piezoelectric transmitter for transmitting acoustic information by modulating the reflection of an external impinging acoustic wave.


The prior art provides various examples of piezoelectric transducers. Examples of such piezoelectric transducers are disclosed in U.S. Pat. Nos. 3,792,204; 4,793,825; 3,894,198; 3,798,473; and 4,600,855.


However, none of the prior art references provide a miniature flexural piezoelectric transducer specifically tailored so as to allow the usage of low frequency acoustic signals for vibrating the piezoelectric layer at its resonant frequency, wherein substantially low frequency signals herein refer to signals having a wavelength that is much larger than the dimensions of the transducer. Further, none of the prior art references provide a miniature transducer having electrodes specifically shaped so as to maximize the electrical output of the transducer. Further, none of the above references provide a transducer element which may be integrally manufactured with any combination of electronic circuits by using photolithographic and microelectronics technologies.


Further, the prior art fails to provide a miniature flexural piezoelectric transmitter which modulates the reflected acoustic wave by controllably changing the mechanical impedance of the piezoelectric layer according to a message signal received from an electronic component such as a sensor. Further, the prior art fails to provide such transmitter wherein the piezoelectric layer is electrically connected to a switching element, the switching element for alternately changing the electrical connections of the transmitter so as to alternately change the mechanical impedance of the piezoelectric layer. Further, the prior art fails to provide such transducer wherein the mechanical impedance of the piezoelectric layer is controlled by providing a plurality of electrodes attached thereto, the electrodes being electrically interconnected in parallel and anti-parallel electrical connections. Further, the prior art fails to provide such transmitter wherein the piezoelectric layer features different polarities at distinct portions thereof. Further, the prior art fails to provide such transmitter which includes a chamber containing a low pressure gas for enabling asymmetrical fluctuations of the piezoelectric layer. Further, the prior art fails to provide such transmitter having a two-ply piezoelectric layer.


SUMMARY OF THE INVENTION

According to one aspect of the present invention there is provided a device for controlled release of molecules comprising: (a) a device body having at least one reservoir therein for containing the molecules, the at least one reservoir being formed with a barrier impermeable to the molecules thereby preventing release thereof from the at least one reservoir; and (b) at least one acoustic transducer being attached to, or forming a part of, the device body, the at least one acoustic transducer being for converting an acoustic signal received thereby into an electrical signal, the electrical signal leading to barrier permeabilization and therefore release of the molecules from the at least one reservoir.


According to an additional aspect of the present invention there is provided a system for localized delivery of molecules within the body comprising: (a) an intrabody implantable device including: (i) a device body having at least one reservoir therein for containing the molecules, the at least one reservoir being formed with a barrier impermeable to the molecules thereby preventing release thereof from the at least one reservoir; and (ii) at least one acoustic transducer being attached to, or forming a part of, the device body, the at least one acoustic transducer being for converting an acoustic signal received thereby into an electrical signal, the electrical signal leading to barrier permeabilization and therefore release of the molecules from the at least one reservoir; and (b) an extracorporeal unit for generating the acoustic signal.


According to another aspect of the present invention there is provided a method of delivering molecules to a specific body region, the method comprising: (a) implanting within the body region a device including: (i) a device body having at least one reservoir therein containing the molecules, the at least one reservoir being formed with a barrier impermeable to the molecules thereby preventing release thereof from the at least one reservoir; and (ii) at least one acoustic transducer being attached to, or forming a part of, the device body, the at least one acoustic transducer being for converting an acoustic signal received thereby into an electrical signal, the electrical signal leading to barrier permeabilization and therefore release of the molecules from the at least one reservoir; and (b) extracorporeally irradiating the body with an acoustic signal thereby causing the subsequent release of the molecules from the at least one reservoir.


According to further features in preferred embodiments of the invention described below, the device further comprising a cathode, and an anode, whereas the electrical signal generates an electric potential between the cathode and the anode leading to permeabilization of the barrier and release of the molecules from the at least one reservoir.


According to still further features in the described preferred embodiments the anode is attached to or forms at least a part of the barrier.


According to still further features in the described preferred embodiments the electrical signal directly generates the electric potential between the cathode and the anode.


According to still further features in the described preferred embodiments the device further comprising a power source for generating the electric potential between the cathode and the anode upon receiving the electrical signal from the at least one acoustic transducer.


According to still further features in the described preferred embodiments the at least one acoustic transducer serves as an acoustic switch.


According to still further features in the described preferred embodiments permeabilization of the barrier is effected by at least partial disintegration thereof.


According to still further features in the described preferred embodiments a type or duration of the electrical signal controls a degree of permeabilization of the barrier and thus an amount of the molecules released.


According to still further features in the described preferred embodiments the device includes a plurality of reservoirs.


According to still further features in the described preferred embodiments the device includes a plurality of acoustic transducers.


According to still further features in the described preferred embodiments each of the plurality of acoustic transducers generates an electrical signal which leads to permeabilization of a barrier of a corresponding reservoir of the plurality of reservoirs.


According to still further features in the described preferred embodiments each of the plurality of acoustic transducers is capable of converting an acoustic signal of a distinct frequency or frequencies into the electrical signal.


According to still further features in the described preferred embodiments the plurality of reservoirs are for containing different types of molecules, different amounts of molecules, or combinations thereof.


According to still further features in the described preferred embodiments the molecules are drug molecules.


According to still further features in the described preferred embodiments the at least one acoustic transducer includes: (i) a cell member having a cavity; (ii) a substantially flexible piezoelectric layer attached to the cell member, the piezoelectric layer having an external surface and an internal surface, the piezoelectric layer featuring such dimensions so as to enable fluctuations thereof at its resonance frequency upon impinging of an external acoustic wave; and (iii) a first electrode attached to the external surface and a second electrode attached to the internal surface.


According to still further features in the described preferred embodiments the device includes a plurality of reservoirs each containing molecules of a specific type and each capable of releasing the molecules upon provision of an acoustic signal of a specific frequency or frequencies, such that a frequency content of the acoustic signal determines a type of the molecules released.


According to an additional aspect of the present invention there is provided a device for controlled drug release comprising: (a) a device body including at least one reservoir being for containing a prodrug form of a drug, the at least one reservoir being formed with a barrier impermeable to the prodrug thereby preventing release thereof from the at least one reservoir; and (b) at least one acoustic transducer being attached to, or forming a part of the device body, the at least one acoustic transducer being for converting an acoustic signal received thereby into an electrical signal, the electrical signal leading to a conversion of the prodrug into the drug, the drug being capable of traversing the barrier thereby releasing from the at least one reservoir.


According to yet an additional aspect of the present invention there is provided a system for localized delivery of molecules within the body comprising: (a) an intrabody implantable device including: (i) a device body including at least one reservoir being for containing a prodrug form of a drug, the at least one reservoir being formed with a barrier impermeable to the prodrug thereby preventing release thereof from the at least one reservoir; and (ii) at least one acoustic transducer being attached to, or forming a part of the device body, the at least one acoustic transducer being for converting an acoustic signal received thereby into an electrical signal, the electrical signal leading to a conversion of the prodrug into the drug, the drug being capable of traversing the barrier thereby releasing from the at least one reservoir; and (b) an extracorporeal unit for generating the acoustic signal.


According to still further features in the described preferred embodiments a type or duration of the electrical signal controls a degree of the conversion and thus an amount of the drug formed and released.


According to still further features in the described preferred embodiments the device includes a plurality of reservoirs and a plurality of acoustic transducers, each of the plurality of acoustic transducers generating an electrical signal which leads to the conversion of the prodrug to the drug contained in a corresponding reservoir of the plurality of reservoirs.


According to still further features in the described preferred embodiments the plurality of reservoirs are for containing different types of prodrugs, different amounts of prodrugs, or combinations thereof.


According to still an additional aspect of the present invention there is provided a method of fabricating a device for controllable release of molecules, the method comprising: (a) providing a substrate; (b) configuring the substrate with the at least one reservoir; (c) capping the at least one reservoir with a cap material which acts as an impermeable barrier to the molecules, the material becoming permeable to the molecules following generation of an electrical potential in or around the at least one reservoir; and (d) providing an inlet port for filling the at least one reservoir with the molecules, the inlet being sealable following the filling, thereby generating the device for controllable release of molecules.


According to still further features in the described preferred embodiments the method further comprising the step of: (e) attaching to, or fabricating within, the substrate, at least one acoustic transducer, the at least one acoustic transducer being for generating an electrical signal from an acoustic signal received thereby, the electrical signal leading to generation of the electrical potential in or around the at least one reservoir.


According to still further features in the described preferred embodiments the at least one acoustic transducer includes: (i) a cell member having a cavity; (ii) a substantially flexible piezoelectric layer attached to the cell member, the piezoelectric layer having an external surface and an internal surface, the piezoelectric layer featuring such dimensions so as to enable fluctuations thereof at its resonance frequency upon impinging of an external acoustic wave; and (iii) a first electrode attached to the external surface and a second electrode attached to the internal surface.


According to still further features in the described preferred embodiments step (b) is effected by etching the substrate.


The present invention successfully addresses the shortcomings of the presently known configurations by providing a device, system and method for efficient intrabody delivery of molecules such as drugs as well as a method of manufacture.


The present invention also relates to a miniature flexural transducer element, comprising, (a) a cell element having a cavity; (b) a substantially flexible piezoelectric layer attached to the cell member, the piezoelectric layer having an external surface and an internal surface, the piezoelectric layer featuring such dimensions so as to enable fluctuations thereof at its resonance frequency upon impinging of an external acoustic wave; and (c) a first electrode attached to the external surface and a second electrode attached to the internal surface of the piezoelectric layer. Preferably, the cavity is etched into a substrate including an electrically insulating layer and an electrically conducting layer. The first electrode is preferably integrally made with a substantially thin electrically conducting layer, the electrically conducting layer being disposed on the substrate and connected thereto by a sealing connection. The cell member may be circular or hexagonal in cross section. According to further features in preferred embodiments of the invention described below, the substrate may include a plurality of cell members electrically connected in parallel or serial connections. Preferably, at least one of the electrodes is specifically shaped so as to provide a maximal electrical output, wherein the electrical output may be current, voltage or power. A preferred shape of the electrodes includes two cores interconnected by a connecting member. A transducer element according to the present invention may also be used as a transmitter.


Preferably, the cavity of the transducer element includes gas of low pressure so as to allow its usage as a transmitter. According to the present invention there is further provided a transmitter element, comprising: (a) a cell element having a cavity; (b) a substantially flexible piezoelectric layer attached to the cell member, the piezoelectric layer having an external surface and an internal surface, the piezoelectric layer featuring such dimensions so as to enable fluctuations thereof at its resonance frequency upon impinging of an external acoustic wave; and (c) a first electrode attached to the external surface and a second electrode attached to the internal surface of the piezoelectric layer, the electrodes being electrically connected to an electrical circuit including a switching element for controllably changing the mechanical impedance of the piezoelectric layer. Preferably, the switching frequency of the switching element equals the frequency of an electrical message signal arriving from an electronic member, such as a sensor, thereby modulating a reflected acoustic wave according to the frequency of the message signal. The transmitter element may include a third electrode attached to the external surface and a fourth electrode attached to the internal surface of the piezoelectric layer. When using such a configuration, the switching element preferably alternately connects the electrodes in parallel and anti-parallel, thereby controllably changing the mechanical impedance of the piezoelectric layer. According to a specific configuration, the electrodes are interconnected by means of a built-in anti-parallel electrical connection. Alternatively, the electrodes may be interconnected by means of a built-in parallel electrical connection. The switching element may be an on/off switch. According to another embodiment, the piezoelectric layer includes first and second portions having opposite polarities. According to yet another embodiment, the transmitter element may include two cell members electrically interconnected by means of a built-in parallel or anti-parallel electrical connection. Alternatively, the switching element may alternately connect the cell members in parallel and anti-parallel electrical connections. The cell members may have piezoelectric layers of opposite polarities. According to yet another embodiment the cavity of the transmitter element is covered by a two-ply piezoelectric layer including an upper layer bonded to a lower layer. The upper and lower layers may feature opposite polarities. The upper and lower layers may be separated by an insulating layer disposed therebetween.


Further according to the present invention there is provided a method of transmitting acoustic information, comprising: (a) providing a substantially flexible piezoelectric layer having first and second electrodes attached thereto, the piezoelectric layer being attached to a cell member, the electrodes being electrically connected to an electrical circuit including a switching element; (b) providing an acoustic wave for impinging on the piezoelectric layer, the acoustic wave having a reflected portion; (c) modulating the reflected portion of the acoustic wave by controlling the mechanical impedance of the piezoelectric layer, said controlling by switching the switching element at a frequency which equals the frequency of a message signal arriving from an electronic component such as a sensor. The method may further comprise: (a) providing third and fourth electrodes attached to the piezoelectric layer, the third and fourth electrodes being electrically connected to the electrical circuit; (b) changing the electrical connections between the electrodes by means of the switching element so as to change the mechanical impedance of the piezoelectric layer. According to a specific configuration, the first and second electrodes are attached to a first cell member and the third and fourth electrodes are attached to a second cell member.


The present invention successfully addresses the shortcomings of the presently known configurations by providing a miniature flexural piezoelectric transducer specifically tailored so as to allow the usage of low frequency acoustic signals for vibrating the piezoelectric layer at its resonant frequency, wherein substantially low frequency signals herein refer to signals having a wavelength that is much larger than dimensions of the transducer. Further, the present invention addresses the shortcomings of the presently known configurations by providing such transducer element having electrodes specifically shaped so as to maximize the electrical output of the transducer, and which may be integrally manufactured with any combination of electronic circuits by using photolithographic and microelectronics technologies.


Further, the present invention addresses the shortcomings of the presently known configurations by providing a miniature flexural piezoelectric transmitter which modulates a reflected acoustic wave by controllably changing the mechanical impedance of the piezoelectric layer according to a message signal received from an electronic component such as a sensor. Further, the present invention addresses the shortcomings of the presently known configurations by providing such transmitter wherein the mechanical impedance of the piezoelectric layer is controlled by providing a plurality of electrodes attached thereto, the electrodes being interconnected in parallel and anti-parallel electrical connections, and wherein at least a portion of the electrodes is electrically connected to a switching element, the switching element for alternately changing the electrical connections between the electrodes so as to alternately change the mechanical impedance of the piezoelectric layer.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention is herein described, by way of example only, with reference to the accompanying drawings. With specific reference now to the drawings in detail, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of the preferred embodiments of the present invention only, and are presented in the cause of providing what is believed to be the most useful and readily understood description of the principles and conceptual aspects of the invention. In this regard, no attempt is made to show structural details of the invention in more detail than is necessary for a fundamental understanding of the invention, the description taken with the drawings making apparent to those skilled in the art how the several forms of the invention may be embodied in practice.



FIG. 1 is a cross sectional view of a general configuration of the device of the present invention;



FIG. 2
a is a longitudinal section of a transducer element according to the present invention taken along lines A-A in FIGS. 3a-3e;



FIG. 2
b is a longitudinal section of a transducer element according to the present invention taken along lines B-B in FIGS. 3a-3e;



FIG. 3
a is a cross section of a transducer element according to the present invention taken along line C-C in FIG. 2a;



FIG. 3
b is a cross section of a transducer element according to the present invention taken along line D-D in FIG. 2a;



FIG. 3
c is a cross section of a transducer element according to the present invention taken along line E-E in FIG. 2a;



FIG. 3
d is a cross section of a transducer element according to the present invention taken along line F-F in FIG. 2a;



FIG. 3
e is a cross section of a transducer element according to the present invention taken along line G-G in FIG. 2a;



FIG. 4 shows the distribution of charge density across a piezoelectric layer of a transducer element resulting from the application of a constant pressure over the entire surface of the layer;



FIGS. 5
a-5d show the results of optimization performed for the power response of a transducer according to the present invention;



FIG. 6 shows a preferred electrode shape for maximizing the power response of a transducer according to the present invention;



FIG. 7 is a longitudinal section of another embodiment of a transducer element according to the present invention capable of functioning as a transmitter;



FIGS. 8
a-8f are schematic views of possible configurations of transmitters according to the present invention including parallel and anti-parallel electrical connections for controllably changing the mechanical impedance of the piezoelectric layer;



FIG. 9 is a longitudinal section of a transmitter element according to the present invention including an anti-parallel electrical connection;



FIG. 10 is a longitudinal section of another embodiment of a transmitter element according to the present invention;



FIG. 11 illustrates a direct activation configuration of a molecule delivery device of the present invention;



FIG. 12 illustrates an indirect activation configuration of a molecule delivery device of the present invention;



FIG. 13 is a schematic diagram illustrating an acoustic switch utilizable by a device of the present invention;



FIG. 14 is a black box diagram of a drug delivery system according to the teachings of the present invention; and



FIG. 15 is schematic diagram illustrating a control circuitry of the acoustic switch illustrated in FIG. 13.





DESCRIPTION OF THE PREFERRED EMBODIMENTS

The present invention is of a device, system, and method which can be used for localized intrabody delivery of molecules. Specifically, the present invention can be used to release molecules such as drugs within a specific body region using an acoustic activation signal provided from outside the body.


The principles and operation of the present invention may be better understood with reference to the drawings and accompanying descriptions.


Before explaining at least one embodiment of the invention in detail, it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of the components set forth in the following description or illustrated in the drawings. The invention is capable of other embodiments or of being practiced or carried out in various ways. Also, it is to be understood that the phraseology and terminology employed herein is for the purpose of description and should not be regarded as limiting.


Referring now to the drawings, FIG. 1 illustrates a device for controlled release of molecules, which is referred to herein as device 10.


Device 10 includes a device body 12 having at least one reservoir 14 formed therein for containing the molecules to be delivered.


Preferably, device body 12 includes a plurality of reservoirs 14 (four shown in FIG. 1) each being configured for containing therapeutic molecules such as drugs and/or diagnostic molecules such as dyes preferably in a solution or as a suspension. Reservoirs 14 can be of various dimensions depending on the molecule type and quantity to be delivered therefrom.


Device body 12 can be of a planar shape, spheroidal shape or any shape suitable for intrabody implantation and delivery of molecules stored thereby. Reservoirs 14 can be formed within a surface of device body 12 or within an interior volume thereof, provided molecules released therefrom can disperse into a medium surrounding device 10.


The dimensions of device 10 are limited by the site of implantation and delivery, the quantity of drugs or drugs to be delivered thereby, and the specific components used thereby for drug release activation.


Reservoirs 14 can be formed within device body 12 using any method known in the art including, but not limited to, etching, machining and the like. Alternatively, device body 12 may be pre-formed with reservoirs 14 by, for example, casting or milling techniques.


Device body 12 is fabricated from a material which is impermeable to the molecules to be delivered and to the surrounding fluids, for example, water, blood, electrolytes or other solutions. Examples of suitable materials include ceramics, semiconductors, biological membranes, and degradable and non-degradable polymers; biocompatibility is preferred, but not required.


For in-vivo applications, non-biocompatible materials may be encapsulated in a biocompatible material, such as polyethyleneglycol or polytetrafluoroethylene-like materials, before use. One example of a strong, non-degradable, easily etched substrate that is impermeable to the molecules to be delivered and the surrounding fluids is silicon.


Alternatively, device body 12 can also be fabricated from a material which degrades or dissolves over a period of time into biocompatible components such as Polyvinyl Alcohol (PVA). This embodiment is preferred for in vivo applications where the device is implanted and physical removal of the device at a later time is not feasible or recommended, as is the case with, for example, brain implants. An example of a class of strong, biocompatible materials are the poly(anhydride-co-imides) discussed by K. E. Uhrich et al., “Synthesis and characterization of degradable poly(an hydride-co-imides)”, Macromolecules, 1995, 28, 2184-93.


Reservoir 14 is formed (capped) with a barrier 16 which is impermeable to the molecules to be delivered. As such barrier 16 serves for preventing molecules contained within reservoir 14 from releasing into the surrounding medium when device 10 is implanted within the body.


Reservoir 14 can be filled with molecules of interest either prior to capping with barrier 16 or following such capping. In the latter case, reservoir 14 also includes an inlet port 18, which serves for filling reservoir 14 with molecules of choice following fabrication of device 10. Inlet port 18 is designed to be sealable following filling, such that accidental drug release therefrom does not occur.


Device 10 further includes at least one acoustic transducer 20. Acoustic transducer 20 can be attached to, or it can form a part of, device body 12. Acoustic transducer 20 serves for converting an acoustic signal received thereby into an electrical signal. The electrical signal generated by transducer 20 is preferably rectified via a full or half-bridge rectifier into a DC current signal. The converted electrical signal can be used to directly or indirectly release the molecules stored in reservoir 14 as described hereinbelow.


According to a preferred embodiment of the present invention, the electrical signal generates (directly or indirectly) an electrical potential within reservoir 14.


To this end, device 10 further includes at least one pair of electrodes 21, which are preferably positioned within reservoir 14 and which serve for providing the electrical potential therein.


According to one preferred embodiment of the present invention, the electrical potential converts the molecules stored within reservoir 14 into an active and barrier permeable form.


For example, the molecules contained within reservoir 14 can be provided as large aggregates which are unable to traverse barrier 16 which can be, in this case, a size selective membrane. Upon provision of the electrical potential the molecules disaggregate into smaller active units which are able to diffuse out of reservoir 14 through barrier 16.


According to another preferred embodiment of the present invention, the electrical potential leads to permeabilization of barrier 16 and subsequent release of the molecules from reservoir 14.


For example, the electrical potential generated by electrodes 21 can cause the partial or full disintegration of barrier 16 and as such the release of the molecules from reservoir 14.


In such a case, barrier 16 can be composed of a thin film of conductive material that is deposited over the reservoir, patterned to a desired geometry, and functions as an anode 22. The size and placement of cathode 23 depends upon the device's application and method of electric potential control.


Conductive materials capable of dissolving into solution or forming soluble compounds or ions upon the application of an electric potential, include, but are not limited to, metals such as copper, gold, silver, and zinc and some polymers.


Thus, according to this configuration of device 10, when an electric potential is applied between anode 22 and cathode 23, the conductive material of the anode above the reservoir oxidizes to form soluble compounds or ions that dissolve into solution, exposing the molecules to be delivered to the surrounding medium.


Alternatively, the application of an electric potential can be used to create changes in local pH near barrier 16 thereby leading to dissolving of barrier 16 and release of the molecules.


Still alternatively, the application of an electric potential can be used to create changes in the net charge of barrier 16 or the net charge or solubility of the molecules thereby enabling barrier 16 traversing.


In any case, the molecules to be delivered are released into the surrounding medium by diffusion out of or by degradation or dissolution of the release system. The frequency and quantity of release can be controlled via the acoustic signal received by acoustic transducer 20 as is further described hereinbelow.



FIGS. 2
a, 2b and 3a-3e illustrate a preferred embodiment of a transducer element according to the present invention. As shown in the figures, the transducer element 20 includes at least one cell member 25 including a cavity 24 etched or drilled into a substrate and covered by a substantially flexible piezoelectric layer 26. Attached to piezoelectric layer 26 are an upper electrode 28 and a lower electrode 30 which are connectable to an electronic circuit. The substrate is preferably made of an electrical conducting layer 32 disposed on an electrically insulating layer 34, such that cavity 24 is etched substantially through the thickness of electrically conducting layer 32.


Electrically conducting layer 32 is preferably made of copper and insulating layer 34 is preferably made of a polymer such as polyimide. Conventional copper-plated polymer laminate such as KAPTON sheets may be used for the production of transducer 20. Commercially available laminates such as NOVOCLAD may be used. Alternatively, the substrate may include a silicon layer, or any other suitable material. Alternatively, layer 32 is made of a non-conductive material such as PYRALIN.


Preferably, cavity 24 is etched into the substrate by using conventional printed-circuit photolithography methods. Alternatively, cavity 24 may be etched into the substrate by using VLSI/micro-machining technology or any other suitable technology.


Piezoelectric layer 26 may be made of PVDF or a copolymer thereof. Alternatively, piezoelectric layer 26 is made of a substantially flexible piezoceramic. Preferably, piezoelectric layer 26 is a poled PVDF sheet having a thickness of about 9-28 μm.


Preferably, the thickness and radius of flexible layer 26, as well as the pressure within cavity 24, are specifically selected so as to provide a predetermined resonant frequency. When using the embodiment of FIGS. 2a and 2b, the radius of layer 26 is defined by the radius of cavity 24.


By using a substantially flexible piezoelectric layer 26, the present invention allows to provide a miniature transducer element whose resonant frequency is such that the acoustic wavelength is much larger than the extent of the transducer. This enables the transducer to be omnidirectional even at resonance, and further allows the use of relatively low frequency acoustic signals which do not suffer from significant attenuation in the surrounding medium.


Prior art designs of miniature transducers, however, rely on rigid piezoceramic usually operating in thickness mode. In such cases the resonant frequency relates to the size of the element and speed of sound in the piezoceramic, and is higher by several orders of magnitude.


The present invention provides a transducer which is omnidirectional, i.e., insensitive to the direction of the impinging acoustic rays, thereby substantially simplifying the transducer's operation relative to other resonant devices. Such a transducer element is thus suitable for application in confined or hidden locations, where the orientation of the transducer element cannot be ascertained in advance.


The configuration and acoustic properties of such an acoustic transducer and variants thereof as well as general acoustic transduction principles are described in detail in U.S. Pat. No. 6,140,740 and PCT Publication No. WO 99/34,453 the disclosures of which are expressly incorporated by reference as if fully set forth herein.


According to a specific embodiment, cavity 24 features a circular or hexagonal shape with radius of about 200 μm. Electrically conducting layer 32 preferably has a thickness of about 15 μm. Cell member 25 is preferably etched completely through the thickness of electrically conducting layer 32.


Electrically insulating layer 34 preferably features a thickness of about 50 μm. The precise dimensions of the various elements of a transducer element according to the present invention may be specifically tailored according to the requirements of the specific application.


Cavity 24 preferably includes a gas such as air. The pressure of gas within cavity 24 may be specifically selected so as to predetermine the sensitivity and ruggedness of the transducer as well as the resonant frequency of layer 26.


As shown in FIG. 3b, an insulating chamber 36 is etched into the substrate, preferably through the thickness of conducting layer 32, so as to insulate the transducer element from other portions of the substrate which may include other electrical components such as other transducer elements etched into the substrate. According to a specific embodiment, the width of insulating chamber 36 is about 100 μm. As shown, insulating chamber 36 is etched into the substrate so as to form a wall 38 of a predetermined thickness enclosing cavity 24, and a conducting line 40 integrally made with wall 38 for connecting the transducer element to another electronic component preferably etched into the same substrate, or to an external electronic circuit.


As shown in FIGS. 2a and 2b, attached to piezoelectric layer 26 are upper electrode 28 and lower electrode 30. As shown in FIGS. 3c and 3e, upper electrode 28 and lower electrode 30 are preferably precisely shaped so as to cover a predetermined area of piezoelectric layer 26. Electrodes 28 and 30 may be deposited on the upper and lower surfaces of piezoelectric membrane 26, respectively, by using various methods such as vacuum deposition, mask etching, painting, and the like.


As shown in FIG. 2a, lower electrode 30 is preferably made as an integral part of a substantially thin electrically conducting layer 42 disposed on electrically conducting layer 32. Preferably, electrically conducting layer 42 is made of a Nickel-Copper alloy and is attached to electrically conducting layer 32 by means of a sealing connection 44. Sealing connection 44 may be made of indium. According to a preferred configuration, sealing connection 44 may feature a thickness of about 10 μm, such that the overall height of wall 38 of cavity 24 is about 20-25 μm.


As shown in FIG. 3c, electrically conducting layer 42 covers the various portions of conducting layer 32, including wall 38 and conducting line 40. The portion of conducting layer 42 covering conducting line 40 is for connection to an electronic component such as a neighboring cell.


According to a preferred embodiment of the present invention, electrodes 28 and 30 are specifically shaped to include the most energy-productive region of piezoelectric layer 26 so as to provide maximal response of the transducer while optimizing the electrode area, and therefore the cell capacitance, thereby maximizing a selected parameter such as voltage sensitivity, current sensitivity, or power sensitivity of the transducer element.


The vertical displacement of piezoelectric layer 26, LP, resulting from a monochromatic excitation at angular frequency ω is modeled using the standard equation for thin plates:









(



2



-

γ
2



)



(



2



-

γ
2



)


Ψ

-



3


(

1
-

v
2


)



2






Qh
3




P

+



3











Z






ω


(

1
-

v
2


)




2






Qh
3





Ψ
_



=
0





wherein Q is the Young's modulus representing the elasticity of layer 26; h the half-thickness of layer 26; v is the Poisson ratio for layer 26; γ is the effective wavenumber in the layer given by: γ4=3ρ(1−v22/Oh2, wherein ρ is the density of layer 26 and ω is the angular frequency of the applied pressure (wherein the applied pressure may include the acoustic pressure, the static pressure differential across layer 26 and any other pressure the transducer comes across); Z is the mechanical impedance resulting from the coupling of layer 26 to both external and internal media of cavity 24, wherein the internal medium is preferably air and the external medium is preferably fluid; P is the acoustic pressure applied to layer 26, and Ψ represents the average vertical displacement of layer 26.


When chamber 24 is circular, the solution (given for a single frequency component ω) representing the dynamic displacement of a circular layer 26 having a predetermined radius a, expressed in polar coordinates, is:







Ψ


(

r
,
φ

)


=






I
1



(

γ





a

)




[



J
0



(

γ





r

)


-


J
0



(

γ





a

)



]


+



J
1



(

γ





a

)




[



I
0



(

γ





r

)


-


I
0



(

γ





a

)



]





2





h





ρ






ω
2




L
0



(

γ





a

)



+







ω







ZL
2



(

γ





a

)






P










L
0



(
z
)


=




I
0



(
z
)





J
1



(
z
)



+



J
0



(
z
)





I
1



(
z
)





,







L
2



(
z
)


=




J
2



(
z
)





I
1



(
z
)



-



I
2



(
z
)





J
1



(
z
)











Z
=



P
A








ω






H
A



+



[


4

3





π


+

1
6


]


φ






ρ
w


a







wherein:


Ψ(r,φ) is time-dependent and represents the displacement of a selected point located on circular layer 26, the specific location of which is given by radius r and angle ω);


J and I are the normal and modified Bessel functions of the first kind, respectively;


PA, HA are the air pressure within cavity 24 and the height of chamber 24, respectively; and


ρw is the density of the fluid external to cavity 24.


The first term of the impedance Z relates to the stiffness resulting from compression of air within cavity 24, and the second term of Z relates to the mass added by the fluid boundary layer. An additional term of the impedance Z relating to the radiated acoustic energy is substantially negligible in this example.


The charge collected between electrodes 28 and 30 per unit area is obtained by evaluating the strains in layer 26 resulting from the displacements, and multiplying by the pertinent off-diagonal elements of the piezoelectric strain coefficient tensor, e31, e32, as follows:







Q


(

r
,
φ
,
t

)


=



(


e
31



(



Ψ



x


)


)

2

+


(


e
32



(



Ψ



y


)


)

2







wherein:


Q(r,φ,t) represents the charge density at a selected point located on circular layer 26, the specific location of which is given by radius r and angle φ;


x is the stretch direction of piezoelectric layer 26;


y is the transverse direction (the direction perpendicular to the stretch direction) of layer 26;


e31, e32 are off-diagonal elements of the piezoelectric strain coefficient tensor representing the charge accumulated at a selected point on layer 26 due to a given strain along the x and y directions, respectively, which coefficients being substantially dissimilar when using a PVDF layer; and


Ψ is the displacement of layer 26, taken as the sum of the displacement for a given acoustic pressure P at frequency f, and the static displacement resulting from the pressure differential between the interior and exterior of cavity 24, which displacements being extractable from the equations given above.


The total charge accumulated between electrodes 28 and 30 is obtained by integrating Q(r,φ,t) over the entire area S of the electrode:

Q=∫SQ(r,φ,t)d x

The capacitance C of piezoelectric layer 26 is given by:







C
=


ɛ

2





h






S












x
_





,





wherein ∈ is the dielectric constant of piezoelectric layer 26; and 2h is the thickness of piezoelectric layer 26.


Accordingly, the voltage, current and power responses of piezoelectric layer 26 are evaluated as follows:







V
=


2





h




N







Q


(

r
,
φ
,
t

)










x
_






ɛ




N












x
_






,





I
=

2











ω




S







Q


(

r
,
φ
,
t

)










x
_






,





W
=


4













h


[



S







Q


(

r
,
φ
,
t

)










x
_




]


2



ɛ




S












x
_










The DC components of Q are usually removed prior to the evaluation, since the DC currents are usually filtered out. The values of Q given above represent peak values of the AC components of Q, and should be modified accordingly so as to obtain other required values such as RMS values.


According to the above, the electrical output of the transducer expressed in terms of voltage, current and power responses depend on the AC components of Q, and on the shape S of the electrodes. Further, as can be seen from the above equations, the voltage response of the transducer may be substantially maximized by minimizing the area of the electrode. The current response, however, may be substantially maximized by maximizing the area of the electrode.



FIG. 4 shows the distribution of charge density on a circular piezoelectric layer 26 obtained as a result of pressure (acoustic and hydrostatic) applied uniformly over the entire area of layer 26, wherein specific locations on layer 26 are herein defined by using Cartesian coordinates including the stretch direction (x direction) and the transverse direction (y direction) of layer 26. It can be seen that distinct locations on layer 26 contribute differently to the charge density. The charge density vanishes at the external periphery 70 and at the center 72 of layer 26 due to minimal deformation of these portions. The charge density is maximal at two cores 74a and 74b located symmetrically on each side of center 72 due to maximal strains (in the stretch direction) of these portions.


A preferred strategy for optimizing the electric responses of the transducer is to shape the electrode by selecting the areas contributing at least a selected threshold percentage of the maximal charge density, wherein the threshold value is the parameter to be optimized. A threshold value of 0% relates to an electrode covering the entire area of layer 26.



FIGS. 5
a-5d show the results of an optimization performed for the power response of a transducer having a layer 26 of a predetermined area. As shown in the figures, the threshold value which provides an optimal power response is about 30% (FIG. 5b). Accordingly, an electrode which covers only the portions of layer 26 contributing at least 30% of the maximal charge density yields a maximal power response. The pertinent voltage response obtained by such an electrode is higher by a factor of 2 relative to an electrode completely covering layer 26 (FIG. 5a). The current response obtained by such electrode is slightly lower relative to an electrode completely covering layer 26 (FIG. 5c). Further as shown in the figures, the deflection of layer 26 is maximal when applying an acoustic signal at the resonant frequency of layer 26 (FIG. 5d).


A preferred electrode shape for maximizing the power response of the transducer is shown in FIG. 6, wherein the electrode includes two electrode portions 80a and 80b substantially covering the maximal charge density portions of layer 26, the electrode portions being interconnected by means of a connecting member 82 having a minimal area. Preferably, portions 80a and 80b cover the portions of layer 26 which yield at least a selected threshold (e.g. 30%) of the maximal charge density.


According to the present invention any other parameter may be optimized so as to determine the shape of electrodes 28 and 30. According to further features of the present invention, only one electrode (upper electrode 28 or lower electrode 30) may be shaped so as to provide maximal electrical response of the transducer, with the other electrode covering the entire area of layer 26. Since the charge is collected only at the portions of layer 26 received between upper electrode 28 and lower electrode 30, such configuration is operatively equivalent to a configuration including two shaped electrodes having identical shapes.


Referring now to FIG. 7, according to another embodiment of the present invention chamber 24 of transducer element 20 may contain gas of substantially low pressure, thereby conferring a substantially concave shape to piezoelectric membrane 26 at equilibrium. Such configuration enables to further increase the electrical response of the transducer by increasing the total charge obtained for a given displacement of layer 26. The total displacement in such an embodiment is given by: Ψ=ρ0ΨDC+ρΨAC cos ωt, wherein P0 is the static pressure differential between the exterior and the interior of cavity 24; ΨDC is the displacement resulting from P0; P is the amplitude of the acoustic pressure; and ΨDC the displacement resulting from P.


Accordingly, the strain along the x direction includes three terms as follows:










S
xx

=




(



Ψ



x


)

2







=





(


P
0
2



(




Ψ
DC




x


)


)

2

+



(


P
2



(




Ψ
AC




x


)


)

2



cos
2


ω





t

+










2






P
0


P





Ψ
DC




x







Ψ
AC




x



cos





ω





t









wherein the DC component is usually filtered out.


Thus, by decreasing the pressure of the medium (preferably air) within cavity 24 relative to the pressure of the external medium (preferably fluid), the value of P0 is increased, thereby increasing the value of the third term of the above equation.


Such embodiment of the present invention makes it possible to increase the charge output of layer 26 for a given displacement, thereby increasing the voltage, current and power responses of the transducer without having to increase the acoustic pressure P. Further, such embodiment enables to further miniaturize the transducer since the same electrical response may obtain for smaller acoustic deflections. Such embodiment is substantially more robust mechanically and therefore more durable than the embodiment shown in FIGS. 2a and 2b. Such further miniaturization of the transducer enables to use higher resonance frequencies relative to the embodiment shown in FIGS. 2a and 2b.


Preferably, a transducer element 20 according to the present invention is fabricated by using technologies which are in wide use in the microelectronics industry so as to allow integration thereof with other conventional electronic components. When the transducer element includes a substrate such as Copper-polymer laminate or silicon, a variety of conventional electronic components may be fabricated onto the same substrate.


According to the present invention, a plurality of cavities 24 may be etched into a single substrate 34 and covered by a single piezoelectric layer 26 so as to provide a transducer element including a matrix of transducing cells members 25, thereby providing a larger energy collecting area of predetermined dimensions while still retaining the advantage of miniature individual transducing cell members 25. When using such configuration, the transducing cell members 25 may be electrically interconnected in parallel or serial connections, or combinations thereof, so as to tailor the voltage and current response of the transducer. Parallel connections are preferably used so as to increase the current output while serial connections are preferably used so as to increase the voltage output of the transducer.


Further, piezoelectric layer 26 may be completely depolarized and then repolarized at specific regions thereof so as to provide a predetermined polarity to each of the transducing cell members 25. Such configuration reduces the complexity of interconnections between the cell members 25.


A transducer element according to the present invention may be further used as a transmitter for transmitting information to a remote receiver by modulating the reflection of an external impinging acoustic wave arrived from a remote transmitter


Referring to FIG. 7, the transducer element shown may function as a transmitter element due to the asymmetric fluctuations of piezoelectric layer 26 with respect to positive and negative transient acoustic pressures obtained as a result of the pressure differential between the interior and exterior of cavity 24.


A transmitter element according to the present invention preferably modulates the reflection of an external impinging acoustic wave by means of a switching element connected thereto. The switching element encodes the information that is to be transmitted, such as the output of a sensor, thereby frequency modulating a reflected acoustic wave.


Such configuration requires very little expenditure of energy from the transmitting module itself, since the acoustic wave that is received is externally generated, such that the only energy required for transmission is the energy of modulation.


Specifically, the reflected acoustic signal is modulated by switching the switching element according to the frequency of a message electric signal arriving from another electronic component such as a sensor, so as to controllably change the mechanical impedance of layer 26 according to the frequency of the message signal.


Preferably, the invention uses a specific array of electrodes connected to a single cell member 25 or alternatively to a plurality of cell members 25 so as to control the mechanical impedance of layer 26.



FIGS. 8
a-8g illustrate possible configurations for controllably changing the impedance of layer 26 of a transmitter element. Referring to FIG. 8a, a transmitter element according to the present invention may include a first and second pairs of electrodes, the first pair including an upper electrode 40a and a lower electrode 38a, and the second pair including an upper electrode 40b and a lower electrode 38b. Electrodes 38a, 38b, 40a and 40b are electrically connected to an electrical circuit by means of conducting lines 36a, 36b, 34a and 34b, respectively, the electrical circuit including a switching element (not shown) so as to alternately change the electrical connections of conducting lines 36a, 36b, 34a and 34b.


Preferably, the switching element switches between a parallel connection and an anti-parallel connection of the electrodes. A parallel connection decreases the mechanical impedance of layer 26, wherein an anti-parallel connection increases the mechanical impedance of layer 26. An anti-parallel connection may be obtained by interconnecting line 34a to 36b and line 34b to 36a. A parallel connection may be obtained by connecting line 34a to 34b and line 36a to 36b. Preferably, the switching frequency equals the frequency of a message signal arriving from an electrical component such as a sensor.


According to another embodiment (FIG. 8b), upper electrode 40a is connected to lower electrode 38b by means of a conducting line 60, and electrodes 38a and 40b are connected to an electrical circuit by means of conducting lines 62 and 64, respectively, the electrical circuit including a switching element. Such configuration provides an anti-parallel connection of the electrodes, wherein the switching element functions as an on/off switch, thereby alternately increasing the mechanical impedance of layer 26.


In order to reduce the complexity of the electrical connections, layer 26 may be depolarized and then repolarized at specific regions thereof. As shown in FIG. 8c, the polarity of the portion of layer 26 received between electrodes 40a and 38a is opposite to the polarity of the portion of layer 26 received between electrodes 40b and 38b. An anti-parallel connection is thus achieved by interconnecting electrodes 38a and 38b by means of a conducting line 60, and providing conducting lines 62 and 64 connected to electrodes 40a and 40b, respectively, the conducting lines for connection to an electrical circuit including a switching element.


According to another embodiment, the transmitting element includes a plurality of transducing cell members, such that the mechanical impedance of layer 26 is controllably changed by appropriately interconnecting the cell members.


As shown in FIG. 8d, a first transducing cell member 25a including a layer 26a and a cavity 24a, and a second transducing cell member 25b including a layer 26b and a cavity 24b are preferably contained within the same substrate; and layers 26a and 26b are preferably integrally made (not shown). A first pair of electrodes including electrodes 28a and 30a is attached to layer 26, and a second pair of electrodes including electrodes 28b and 30b is attached to layer 26b. Electrodes 28a, 30a, 28b and 30b are electrically connected to an electrical circuit by means of conducting lines 37a, 35a, 37b and 35b, respectively, the electrical circuit including a switching element so as to alternately switch the electrical connections of conducting lines 37a, 35a, 37b and 35b so as to alternately provide parallel and anti-parallel connections, substantially as described for FIG. 8a, thereby alternately decreasing and increasing the mechanical impedance of layers 26a and 26b.



FIG. 8
e illustrates another embodiment, wherein the first and second transducing cell members are interconnected by means of an anti-parallel connection. As shown in the figure, the polarity of layer 26a is opposite to the polarity of layer 26b so as to reduce the complexity of the electrical connections between cell members 25a and 25b. Thus, electrode 30a is connected to electrode 30b by means of a conducting line 90, and electrodes 28a and 28b are provided with conducting lines 92 and 94, respectively, for connection to an electrical circuit including a switching element, wherein the switching element preferably functions as an on/off switch so as to alternately increase the mechanical impedance of layers 26a and 26b.



FIG. 8
f shows another embodiment, wherein the first and second transducing cell members are interconnected by means of a parallel connection. As shown, electrodes 30a and 30b are interconnected by means of conducting line 96, electrodes 28a and 28b are interconnected by means of conducting line 98, and electrodes 30b and 28b are provided with conducting lines 100 and 102, respectively, the conducting lines for connection to an electrical circuit including a switching element. The switching element preferably functions as an on/off switch for alternately decreasing and increasing the mechanical impedance of layers 26a and 26b.



FIG. 9 shows a possible configuration of two transducing cell members etched onto the same substrate and interconnected by means of an anti-parallel connection. As shown in the figure, the transducing cell members are covered by a common piezoelectric layer 26, wherein the polarity of the portion of layer 26 received between electrodes 30a and 28a is opposite to the polarity of the portion of layer 26 received between electrodes 30b and 28b. Electrodes 28a and 28b are bonded by means of a conducting line 80, and electrodes 30a and 30b are provided with conducting lines 44 for connection to an electrical circuit.


Another embodiment of a transmitter element according to the present invention is shown in FIG. 10. The transmitter element includes a transducing cell member having a cavity 24 covered by a first and second piezoelectric layers, 50a and 50b, preferably having opposite polarities. Preferably, layers 50a and 50b are interconnected by means of an insulating layer 52. Attached to layer 50a are upper and lower electrodes 44a and 42a, and attached to layer 50b are upper and lower electrodes 44b and 42b. Electrodes 44a, 42a, 44b and 42b are provided with conducting lines 54, 55, 56 and 57, respectively, for connection to an electrical circuit.


It will be appreciated that the above descriptions ate intended only to serve as examples, and that many other embodiments are possible within the spirit and the scope of the present invention.


As mentioned hereinabove, in those embodiments in which the acoustic transducer 20 is used with device 10, the electrical signal generated by the acoustic transducer 20 can directly or indirectly activate the release of the molecules from reservoir 14.


In a direct activation embodiment of device 10 which is specifically shown in FIG. 11, the electrical signal generated by acoustic transducer 20 is communicated directly (via circuitry) to electrodes 21 to thereby generate the electrical potential.


It will be appreciated that in such cases, the degree of barrier permeabilization and as such the degree of drug release can be controlled by the duration and/or frequency of the acoustic signal and/or its intensity received by acoustic transducer 20.


It will further be appreciated that in cases where device 10 includes a plurality of reservoirs, several acoustic transducers can be utilized such that various activation schemes can be employed.


For example, device 10 can include a plurality of acoustic transducers 20 each dedicated to a specific reservoir of reservoirs 14. In such a case, each acoustic transducer 20 can function within a specific frequency range and as such activate release from a specific reservoir 14 only upon reception of an acoustic signal of a specific frequency or frequency range.


Such a configuration enables selective activation of specific reservoirs enabling control over the amount and rate of molecules released as well as enabling control over the type of molecules released, in cases where specific molecules are stored within specific reservoirs.


In an indirect activation embodiment of device 10 shown in FIG. 12, the electrical signal generated by acoustic transducer 20 serves to activate an energy storage device 104 which in turn generates the electrical potential between electrodes 21.


In such cases, acoustic transducer 20 preferably forms a part of an acoustic switch 106 which can be configured as described below.


As specifically shown in FIG. 13, acoustic switch 106 includes an electrical circuit 108 configured for performing one or more functions or commands when activated.


Acoustic switch 106 further includes an energy storage device 104 (power source) and an acoustic transducer 20 coupled to electrical circuit 108 and energy storage device 104.


In addition, acoustic switch 106 also includes a switch 110, such as the switch described in the Examples section below, although alternatively other switches, such as a miniature electromechanical switch and the like (not shown) may be provided.


Energy storage device 104 may be any of a variety of known devices, such as an energy exchanger, a battery and/or a capacitor (not shown). Preferably, energy storage device 104 is capable of storing electrical energy substantially indefinitely. In addition, energy storage device 104 may be capable of being charged from an external source, e.g., inductively, as will be appreciated by those skilled in the art. In a preferred embodiment, energy storage device 104 includes both a capacitor and a primary, non-rechargeable battery. Alternatively, energy storage device 104 may include a secondary, rechargeable battery and/or capacitor that may be energized before activation or use of acoustic switch 106.


Acoustic switch 106 operates in one of two modes, a “sleep” or “passive” mode when not in use, and an “active” mode, when commanding electrical energy delivery from energy storage device 104 to electrical circuit 108 in order to activate release of molecules from reservoir 14 as described hereinabove.


When in the sleep mode, there is substantially no energy consumption from energy storage device 104, and consequently, acoustic switch 106 may remain in the sleep mode virtually indefinitely, i.e., until activated. Thus, acoustic switch 106 may be more energy efficient and, therefore, may require a smaller capacity energy storage device 104 than power switching devices that continuously draw at least a small amount of current in their “passive” mode.


To activate the acoustic switch, one or more external acoustic energy waves or signals 112 are transmitted until a signal is received by acoustic transducer 20. Upon excitation by acoustic wave(s) 112, acoustic transducer 20 produces an electrical output that is used to close, open, or otherwise activate switch 110. Preferably, in order to achieve reliable switching, acoustic transducer 20 is configured to generate a voltage of at least several tenths of a volt upon excitation that may be used as an activation signal to close switch 110.


As a safety measure against false positives (either erroneous activation or deactivation), switch 110 may be configured to close only upon receipt of an initiation signal followed by a confirmation signal. For example, an activation signal that includes a first pulse followed by a second pulse separated by a predetermined delay may be employed.


It will be appreciated that in the case of device 10 of the present invention, the use of a confirmation signal may be particularly advantageous since it can prevent unintentional release of drugs.


In addition to an activation signal, acoustic transducer 20 may be configured for generating a termination signal in response to a second acoustic excitation (which may be of different frequency or duration than the activation signal) in order to return acoustic switch 106 to its sleep mode.


For example, once activated, switch 110 may remain closed indefinitely, e.g., until energy storage device 104 is depleted or until a termination signal is received by acoustic transducer 20. Alternatively, acoustic switch 106 may include a timer (not shown), such that switch 110 remains closed only for a predetermined time, whereupon it may automatically open, returning acoustic switch 106 to its sleep mode.


Acoustic switch 106 may also include a microprocessor unit which serves to interpret the electrical signal provided from acoustic transducer 20 (e.g., frequency thereof) into a signal for switching switch 110.


Such interpretation enables to modulate the duration and strength of an electrical potential provided within reservoir 14 by simply varying the frequency and/or duration and/or intensity modulation of the acoustic signal provided from outside the body.


Additional acoustic switch configurations which are utilizable by the present invention are described in U.S. Pat. No. 6,628,989, the disclosure of which is expressly incorporated by reference as if fully set forth herein.


Device 10 of the present invention can form a part of a system for localized release of, for example, drugs, which is referred to herein as system 114.


As shown in FIG. 14, system 114 also includes an extracorporeal unit 116 which serves for generating an acoustic signal outside the body, which acoustic signal is received by device 10 implanted within the body. Numerous devices capable of generating an acoustic signal which can serve as extracorporeal unit 116 are known in the art, and as such no further description thereof is given herein.


System 114 can be used as follows. A device 10 filled with molecules is implanted within a specific body tissue. Following implantation, extracorporeal unit 116 generates an acoustic signal of a predetermined frequency and/or duration thereby activating release of the molecules from device 10 as described hereinabove.


Thus, the present invention provides a device, system and method useful for localized delivery of molecules such as drugs.


The device of the present invention provides several advantages over prior art devices such as those described in U.S. Pat. Nos. 6,123,861 and 5,797,898. Such advantages are afforded by the acoustic transducer component of the device which functions in converting an acoustic signal into an electrical activation signal.


In sharp contrast, the device described in U.S. Pat. Nos. 6,123,861 and 5,797,898, employs radiofrequency (RF) receivers which activate drug release upon reception of an RF signal generated outside the body. The use of RF activation is disadvantageous since RF signals are, at least in part, absorbed by body tissues and are directionally limited by bulky unidirectional antennas used for reception.


On the other hand, acoustic transducers, such as the one utilized by the device of the present invention, are omni-directional receivers which do not require antennas and as such do not suffer from structural and functional limitations which are inherent to RF receivers.


In addition, acoustic activation requires far less energy than RF activation since acoustic waves, unlike RF waves, propagate well within the aqueous medium which forms a substantial part of body tissues.


Additional objects, advantages, and novel features of the present invention will become apparent to one ordinarily skilled in the art upon examination of the following examples, which are not intended to be limiting. Additionally, each of the various embodiments and aspects of the present invention as delineated hereinabove find experimental support in the following examples.


EXAMPLES
Acoustic Switch Circuitry and Function

Referring again to the drawings, FIG. 15, illustrates an example of circuitry and components employed by an acoustic switch 200 which is utilizable by the device of the present invention.


Switch 200 includes a piezoelectric transducer, or other acoustic transducer such the acoustic transducer described hereinabove (not shown, but connectable at locations piezo + and piezo −), a plurality of MOSFET transistors (Q1-Q4) and resistors (R1-R4), and switch 51.


In the switch's “sleep” mode, all of the MOSFET transistors (Q1-Q4) are in an off state. To maintain the off state, the gates of the transistors are biased by pull-up and pull-down resistors. The gates of N-channel transistors (Q1, Q3 & Q4) are biased to ground and the gate of P-channel transistor Q2 is biased to +3V. During this quiescent stage, switch S1 is closed and no current flows through the circuit.


Therefore, although an energy storage device (not shown, but coupled between the hot post, labeled with an exemplary voltage of +3V, and ground) is connected to the switch 200, no current is being drawn therefrom since all of the transistors are quiescent.


When the piezoelectric transducer detects an external acoustic signal, e.g., having a particular frequency such as the transducer's resonant frequency, the voltage on the transistor Q1 will exceed the transistor threshold voltage of about one half of a volt. Transistor Q1 is thereby switched on and current flows through transistor Q1 and pull-up resistor R2. As a result of the current flow through transistor Q1, the voltage on the drain of transistor Q1 and the gate of transistor Q2 drops from +3V substantially to zero (ground). This drop in voltage switches on the P-channel transistor Q2, which begins to conduct through transistor Q2 and pull-down resistor R3.


As a result of the current flowing through transistor Q2, the voltage on the drain of transistor Q2 and the gates of transistors Q3 and Q4 increases from substantially zero to +3V. The increase in voltage switches on transistors Q3 and Q4. As a result, transistor Q3 begins to conduct through resistor R4 and main switching transistor Q4 begins to conduct through the “load,” thereby switching on the electrical circuit.


As a result of the current flowing through transistor Q3, the gate of transistor Q2 is connected to ground through transistor Q3, irrespective of whether or not transistor Q1 is conducting. At this stage, the transistors (Q2, Q3 & Q4) are latched to the conducting state, even if the piezoelectric voltage on transistor Q1 is subsequently reduced to zero and transistor Q1 ceases to conduct. Thus, main switching transistor Q4 will remain on until switch S1 is opened.


In order to deactivate or open switch 200, switch S1 must be opened, for example, while there is no acoustic excitation of the piezoelectric transducer. If this occurs, the gate of transistor Q2 increases to +3V due to pull-up resistor R2. Transistor Q2 then switches off, thereby, in turn, switching off transistors Q3 and Q4. At this stage, switch 200 returns to its sleep mode, even if switch SI is again closed. Switch 200 will only return to its active mode upon receiving a new acoustic activation signal from the piezoelectric transducer.


It should be apparent to one of ordinary skill in the art that the above-mentioned electrical circuit is not the only possible implementation of a switch for use with the present invention. For example, the switching operation may be performed using a CMOS circuit, which may draw less current when switched on, an electromechanical switch, and the like.


It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination.


Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications and variations that fall within the spirit and broad scope of the appended claims. All publications, patents and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent, or patent application was specifically and individually indicated to be incorporated herein by reference. In addition, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present invention.

Claims
  • 1. A transducer element, comprising: a cell member including at least one cavity;a piezoelectric layer coupled to a periphery of the cell member so as to isolate the cavity from an external fluid medium, the piezoelectric layer having a concave shape and including an external surface and an internal surface, wherein a central portion of the piezoelectric layer is freely suspended over the cavity;a first electrode attached to the external surface of the piezoelectric layer and a second electrode attached to the internal surface of the piezoelectric layer, the first and second electrodes coupled to an electrical circuit; andwherein the piezoelectric layer is configured to fluctuate in and out of the cavity at a frequency corresponding to a resonance frequency of the layer and acoustically transmit a signal based on a message signal received from a sensor.
  • 2. The transducer element of claim 1, wherein the cavity is etched into a substrate.
  • 3. The transducer element of claim 2, wherein the substrate includes an electrically insulating layer and an electrically conductive layer.
  • 4. The transducer element of claim 1, wherein the cavity is circular in cross-section.
  • 5. The transducer element of claim 1, wherein the cavity is hexagonal in cross-section.
  • 6. The transducer element of claim 1, wherein the at least one cavity includes a plurality of cavities covered by a single piezoelectric layer, the plurality of cavities forming a matrix of transducing cell members.
  • 7. The transducer element of claim 1, wherein the cavity includes a gas.
  • 8. The transducer element of claim 7, wherein the pressure of the gas is lower than the pressure of the external fluid medium.
  • 9. The transducer element of claim 1, wherein the cavity has an acoustic impedance lower than an acoustic impedance of the external fluid medium.
  • 10. The transducer element of claim 1, wherein the piezoelectric layer comprises a PVDF material.
  • 11. The transducer element of claim 1, wherein at least one of the first and second electrodes comprises two electrode portions interconnected by a connecting member.
  • 12. The transducer element of claim 11, wherein the two electrode portions are symmetrically located on each side of the central portion of the piezoelectric layer.
  • 13. The transducer element of claim 1, wherein at least one of the first and second electrodes covers only a portion of a surface of the piezoelectric layer.
  • 14. The transducer element of claim 1, wherein the first and second electrodes cover a surface of the piezoelectric layer at a location spaced apart from the central portion and periphery of the piezoelectric layer.
  • 15. The transducer element of claim 1, wherein the thickness of the piezoelectric layer is about 9 to 28 μm.
  • 16. The transducer element of claim 1, wherein the radius of the cavity is about 200 μm.
  • 17. The transducer element of claim 1, wherein the piezoelectric layer is configured to fluctuate in and out of the cavity at its resonance frequency upon impingement of an external acoustic field transmitted through the external fluid medium, the resonance frequency determined by the physical dimensions of the cavity and the piezoelectric layer, wherein the wavelength of the acoustic field is substantially larger than said dimensions.
  • 18. The transducer element of claim 1, wherein the transducer element is a transmitter.
  • 19. A biosensor for implantation within a body, the biosensor comprising: a sensor; anda transducer element coupled to the sensor, the transducer element configured to acoustically transmit a signal based on a message signal received from the sensor and including: a cell member including at least one cavity;a piezoelectric layer coupled to a periphery of the cell member so as to isolate the cavity from an external fluid medium, the piezoelectric layer having a concave shape and including an external surface and an internal surface, wherein a central portion of the piezoelectric layer is freely suspended over the cavity; anda first electrode attached to the external surface of the piezoelectric layer and a second electrode attached to the internal surface of the piezoelectric layer, the first and second electrodes coupled to an electrical circuit.
  • 20. A system for transmitting information within a body, the system comprising: a sensor;a transducer element coupled to the sensor, the transducer element including: a cell member including at least one cavity;a piezoelectric layer coupled to a periphery of the cell member so as to isolate the cavity from an external fluid medium, the piezoelectric layer having a concave shape and including an external surface and an internal surface, wherein a central portion of the piezoelectric layer is freely suspended over the cavity; anda first electrode attached to the external surface of the piezoelectric layer and a second electrode attached to the internal surface of the piezoelectric layer, the first and second electrodes coupled to an electrical circuit; anda remote receiver configured to receive an acoustic wave transmitted by the transducer element.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of co-pending U.S. application Ser. No. 10/638,405, filed Aug. 12, 2003, now U.S. Pat. No. 7,621,905, which is a continuation of U.S. application Ser. No. 09/930,455, filed Aug. 16, 2001, now abandoned, and which is also a continuation-in-part of U.S. application Ser. No. 10/235,968, filed Sep. 6, 2002, now U.S. Pat. No. 6,720,709, which is a continuation of U.S. application Ser. No. 09/691,887, filed Oct. 20, 2000, now U.S. Pat. No. 6,504,286, which is a continuation of U.S. application Ser. No. 09/000,553, filed Dec. 30, 1997, now U.S. Pat. No. 6,140,740, all of which are incorporated herein by reference in their entireties for all purposes.

US Referenced Citations (534)
Number Name Date Kind
2967957 Massa Jan 1961 A
3310885 Alderson Mar 1967 A
3320946 Dethloff et al. May 1967 A
3536836 Pfeiffer Oct 1970 A
3568661 Franklin Mar 1971 A
3672352 Summers Jun 1972 A
3676720 Libby et al. Jul 1972 A
3692027 Ellinwood Sep 1972 A
3757770 Brayshaw et al. Sep 1973 A
3792204 Murayama et al. Feb 1974 A
3794840 Scott Feb 1974 A
3798473 Murayama et al. Mar 1974 A
3832580 Yamamuro et al. Aug 1974 A
3868578 Oldham Feb 1975 A
3894198 Murayama et al. Jul 1975 A
3940637 Ohigashi et al. Feb 1976 A
3943915 Severson Mar 1976 A
3978353 Kinoshita Aug 1976 A
4003379 Ellinwood Jan 1977 A
4008408 Kodama Feb 1977 A
4041954 Ohara Aug 1977 A
4051455 Fowler Sep 1977 A
4056742 Tibbetts Nov 1977 A
4064375 Russell et al. Dec 1977 A
4096756 Alphonse Jun 1978 A
4127110 Bullara Nov 1978 A
4146029 Ellinwood Mar 1979 A
4170742 Itagaki et al. Oct 1979 A
4181864 Etzold Jan 1980 A
4223801 Carlson Sep 1980 A
4227407 Drost Oct 1980 A
4237900 Schulman et al. Dec 1980 A
4281484 Massa Aug 1981 A
4281664 Duggen Aug 1981 A
4360019 Portner et al. Nov 1982 A
4407296 Anderson Oct 1983 A
4431873 Dunn et al. Feb 1984 A
4433400 De Reggi et al. Feb 1984 A
4440983 Facoetti et al. Apr 1984 A
4450527 Sramek May 1984 A
4456850 Inoue et al. Jun 1984 A
4480483 McShane Nov 1984 A
4481950 Duggan Nov 1984 A
4517665 De Reggi et al. May 1985 A
4519401 Ko et al. May 1985 A
4541431 Ibrahim et al. Sep 1985 A
4543955 Schroeppel Oct 1985 A
4550370 Baker Oct 1985 A
4558249 Lerch et al. Dec 1985 A
4577132 Ohigashi et al. Mar 1986 A
4580074 Gilman Apr 1986 A
4583553 Shah et al. Apr 1986 A
4585004 Brownlee Apr 1986 A
4593703 Cosman Jun 1986 A
4600855 Strachan Jul 1986 A
4616640 Kaali et al. Oct 1986 A
4642508 Suzuki et al. Feb 1987 A
4651740 Schroeppel Mar 1987 A
4653036 Harris et al. Mar 1987 A
4653508 Cosman Mar 1987 A
4660568 Cosman Apr 1987 A
4672976 Kroll Jun 1987 A
4676255 Cosman Jun 1987 A
4677337 Kleinschmidt et al. Jun 1987 A
4677985 Bro et al. Jul 1987 A
4680957 Dodd Jul 1987 A
4686987 Salo et al. Aug 1987 A
4697595 Breyer et al. Oct 1987 A
4716903 Hansen et al. Jan 1988 A
4726380 Vollmann et al. Feb 1988 A
4768176 Kehr et al. Aug 1988 A
4768177 Kehr et al. Aug 1988 A
4781715 Wurzel Nov 1988 A
4791936 Snell et al. Dec 1988 A
4793825 Benjamin et al. Dec 1988 A
4793827 Lochow et al. Dec 1988 A
4809697 Causey, III et al. Mar 1989 A
4814974 Narayanan et al. Mar 1989 A
4835435 Yeung et al. May 1989 A
4845503 Adam et al. Jul 1989 A
4846191 Brockway et al. Jul 1989 A
4854327 Kunig Aug 1989 A
4899752 Cohen Feb 1990 A
4909259 Tehrani Mar 1990 A
4911172 Bui et al. Mar 1990 A
4920489 Hubelbank et al. Apr 1990 A
4945477 Edwards Jul 1990 A
4945914 Allen Aug 1990 A
4958100 Crawley et al. Sep 1990 A
4967749 Cohen Nov 1990 A
4986270 Cohen Jan 1991 A
4991579 Allen Feb 1991 A
4992692 Dias Feb 1991 A
4995068 Chou et al. Feb 1991 A
4995398 Turnidge Feb 1991 A
5002062 Suzuki Mar 1991 A
5003976 Alt Apr 1991 A
5007431 Donehoo, III Apr 1991 A
5012815 Bennett, Jr. et al. May 1991 A
5024224 Engebretson Jun 1991 A
5025795 Kunig Jun 1991 A
5029582 Lekholm Jul 1991 A
5040536 Riff Aug 1991 A
5040538 Mortazavi Aug 1991 A
5052399 Olive et al. Oct 1991 A
5088576 Potthoff et al. Feb 1992 A
5113859 Funke May 1992 A
5126589 Renger Jun 1992 A
5154171 Chirife Oct 1992 A
5160870 Carson et al. Nov 1992 A
5161536 Vilkomerson et al. Nov 1992 A
5163429 Cohen Nov 1992 A
5178151 Sackner Jan 1993 A
5178153 Einzig Jan 1993 A
5190035 Salo et al. Mar 1993 A
5199428 Obel et al. Apr 1993 A
5200891 Kehr et al. Apr 1993 A
5213098 Bennett et al. May 1993 A
5215098 Steinhaus et al. Jun 1993 A
5217021 Steinhaus et al. Jun 1993 A
5246008 Mueller Sep 1993 A
5263486 Jeffreys Nov 1993 A
5267174 Kaufman et al. Nov 1993 A
5277191 Hughes Jan 1994 A
5279309 Taylor et al. Jan 1994 A
5279607 Schentag et al. Jan 1994 A
5283397 Pavlovic Feb 1994 A
5289821 Swartz Mar 1994 A
5300092 Schaldach Apr 1994 A
5300875 Tuttle Apr 1994 A
5309919 Snell et al. May 1994 A
5312446 Holschbach et al. May 1994 A
5313953 Yomtov et al. May 1994 A
5314457 Jeutter et al. May 1994 A
5329459 Kaufman et al. Jul 1994 A
5330505 Cohen Jul 1994 A
5331966 Bennett et al. Jul 1994 A
5339051 Koehler et al. Aug 1994 A
5339290 Greenstein Aug 1994 A
5354316 Keimel Oct 1994 A
5360440 Andersen Nov 1994 A
5367500 Ng Nov 1994 A
5368040 Carney Nov 1994 A
5375603 Feiler Dec 1994 A
5381067 Greenstein et al. Jan 1995 A
5381386 Lum et al. Jan 1995 A
5394457 Leibinger et al. Feb 1995 A
5397329 Allen Mar 1995 A
5410587 Grunwell Apr 1995 A
5411535 Fujii et al. May 1995 A
5411551 Winston et al. May 1995 A
5417717 Salo et al. May 1995 A
5423334 Jordan Jun 1995 A
5438553 Wilson et al. Aug 1995 A
5438990 Wahlstrand et al. Aug 1995 A
5442351 Horspool et al. Aug 1995 A
5445608 Chen et al. Aug 1995 A
5454838 Vallana et al. Oct 1995 A
5458627 Baranowski, Jr. et al. Oct 1995 A
5469859 Tsoglin et al. Nov 1995 A
5476488 Morgan et al. Dec 1995 A
5483501 Park et al. Jan 1996 A
5488954 Sleva et al. Feb 1996 A
5490962 Cima et al. Feb 1996 A
5495137 Park et al. Feb 1996 A
5507780 Finch Apr 1996 A
5509424 Al-Ali Apr 1996 A
5518001 Snell May 1996 A
5528067 Farb Jun 1996 A
5535752 Halperin et al. Jul 1996 A
5545186 Olson et al. Aug 1996 A
5554177 Kieval et al. Sep 1996 A
5558091 Acker et al. Sep 1996 A
5562714 Grevious Oct 1996 A
5564434 Halperin et al. Oct 1996 A
5571152 Chen et al. Nov 1996 A
5603331 Heemels et al. Feb 1997 A
5604531 Iddan et al. Feb 1997 A
5619997 Kaplan Apr 1997 A
5623935 Faisandier Apr 1997 A
5626630 Markowitz et al. May 1997 A
5628782 Myers May 1997 A
5642731 Kehr Jul 1997 A
5643327 Dawson et al. Jul 1997 A
5656428 McAllister et al. Aug 1997 A
5679026 Fain et al. Oct 1997 A
5704352 Tremblay et al. Jan 1998 A
5705753 Hastings et al. Jan 1998 A
5709216 Woodson, III Jan 1998 A
5728281 Holmstrom et al. Mar 1998 A
5729129 Acker Mar 1998 A
5732708 Nau et al. Mar 1998 A
5733313 Barreras, Sr. et al. Mar 1998 A
5735887 Barreras, Sr. et al. Apr 1998 A
5741316 Chen et al. Apr 1998 A
5749909 Schroeppel et al. May 1998 A
5752235 Kehr et al. May 1998 A
5752976 Duffin et al. May 1998 A
5755766 Chastain et al. May 1998 A
5757104 Getman et al. May 1998 A
5769877 Barreras, Sr. Jun 1998 A
5772999 Greenblatt et al. Jun 1998 A
5776168 Gunderson Jul 1998 A
5776324 Usala Jul 1998 A
5779634 Ema et al. Jul 1998 A
5785660 van Lake et al. Jul 1998 A
5792195 Carlson et al. Aug 1998 A
5796827 Coppersmith et al. Aug 1998 A
5797898 Santini et al. Aug 1998 A
5800478 Chen et al. Sep 1998 A
5804258 Lohwasser et al. Sep 1998 A
5807258 Cimochowski et al. Sep 1998 A
5807395 Mulier et al. Sep 1998 A
5807397 Barreras Sep 1998 A
5810009 Mine et al. Sep 1998 A
5810735 Halperin et al. Sep 1998 A
5819740 Muhlenberg et al. Oct 1998 A
5825117 Ossmann et al. Oct 1998 A
5832924 Archibald et al. Nov 1998 A
5833603 Kovacs et al. Nov 1998 A
5833715 Vachon et al. Nov 1998 A
5835455 Hanson et al. Nov 1998 A
5836300 Mault Nov 1998 A
5836889 Wyborny et al. Nov 1998 A
5836982 Muhlenberg et al. Nov 1998 A
5843089 Sahatijan et al. Dec 1998 A
5843135 Weijand et al. Dec 1998 A
5855609 Knapp Jan 1999 A
5856722 Haronian et al. Jan 1999 A
5868673 Vesely Feb 1999 A
5870351 Ladabaum et al. Feb 1999 A
5873835 Hastings et al. Feb 1999 A
5873904 Ragheb et al. Feb 1999 A
5879283 Adams et al. Mar 1999 A
5880661 Davidson et al. Mar 1999 A
5886267 Ortiz Mar 1999 A
5891180 Greeninger et al. Apr 1999 A
5904708 Goedeke May 1999 A
5908392 Wilson et al. Jun 1999 A
5911685 Siess et al. Jun 1999 A
5919221 Miesel Jul 1999 A
5935081 Kadhiresan Aug 1999 A
5938903 Broderick Aug 1999 A
5941249 Maynard Aug 1999 A
5951458 Hastings et al. Sep 1999 A
5954641 Kehr et al. Sep 1999 A
5956292 Bernstein Sep 1999 A
5957950 Mockros et al. Sep 1999 A
5967986 Cimochowski et al. Oct 1999 A
5976169 Imran Nov 1999 A
5980554 Lenker et al. Nov 1999 A
6002963 Mouchawar et al. Dec 1999 A
6009472 Boudou et al. Dec 1999 A
6021347 Herbst et al. Feb 2000 A
6023641 Thompson Feb 2000 A
6024704 Meador et al. Feb 2000 A
6044298 Salo et al. Mar 2000 A
6048328 Haller et al. Apr 2000 A
6053873 Govari et al. Apr 2000 A
6058329 Salo et al. May 2000 A
6068589 Neukermans May 2000 A
6080190 Schwartz Jun 2000 A
6082367 Greeninger et al. Jul 2000 A
6083248 Thompson Jul 2000 A
6112116 Fischell et al. Aug 2000 A
6123861 Santini, Jr. et al. Sep 2000 A
6140740 Porat et al. Oct 2000 A
6141588 Cox et al. Oct 2000 A
6152885 Taepke Nov 2000 A
6155267 Nelson Dec 2000 A
6161032 Acker Dec 2000 A
6162238 Kaplan et al. Dec 2000 A
6164284 Schulman et al. Dec 2000 A
6170488 Spillman, Jr. et al. Jan 2001 B1
6171252 Roberts Jan 2001 B1
6179767 Ziegler et al. Jan 2001 B1
6185452 Schulman et al. Feb 2001 B1
6185455 Loeb et al. Feb 2001 B1
6185457 Kroll et al. Feb 2001 B1
6198965 Penner et al. Mar 2001 B1
6200265 Walsh et al. Mar 2001 B1
6201991 Chekanov Mar 2001 B1
6206914 Soykan et al. Mar 2001 B1
6223081 Kerver Apr 2001 B1
6227078 Lemmo, Jr. May 2001 B1
6234973 Meador et al. May 2001 B1
6236889 Soykan et al. May 2001 B1
6237398 Porat et al. May 2001 B1
6239724 Doron et al. May 2001 B1
6248080 Miesel et al. Jun 2001 B1
6253260 Beardsley et al. Jun 2001 B1
6256538 Ekwall Jul 2001 B1
6266567 Ishikawa et al. Jul 2001 B1
6273904 Chen et al. Aug 2001 B1
6277078 Porat et al. Aug 2001 B1
6278894 Salo et al. Aug 2001 B1
6287332 Bolz et al. Sep 2001 B1
6305381 Weijand et al. Oct 2001 B1
6308099 Fox et al. Oct 2001 B1
6330957 Bell-Greenstreet Dec 2001 B1
6331163 Kaplan Dec 2001 B1
6347245 Lee et al. Feb 2002 B1
6366808 Schroeppel et al. Apr 2002 B1
6368275 Sliwa et al. Apr 2002 B1
6397661 Grimes et al. Jun 2002 B1
6409675 Turcott Jun 2002 B1
6411850 Kay et al. Jun 2002 B1
6416474 Penner et al. Jul 2002 B1
6431175 Penner et al. Aug 2002 B1
6432050 Porat et al. Aug 2002 B1
6438408 Mulligan et al. Aug 2002 B1
6441747 Khair et al. Aug 2002 B1
6442413 Silver Aug 2002 B1
6445953 Bulkes et al. Sep 2002 B1
6456883 Torgerson et al. Sep 2002 B1
6471645 Warkentin et al. Oct 2002 B1
6472991 Schulman et al. Oct 2002 B1
6475170 Doron et al. Nov 2002 B1
6477406 Turcott Nov 2002 B1
6480733 Turcott Nov 2002 B1
6486588 Doron et al. Nov 2002 B2
6491666 Santini, Jr. et al. Dec 2002 B1
6504286 Porat et al. Jan 2003 B1
6504289 Toda et al. Jan 2003 B2
6522914 Huvelle et al. Feb 2003 B1
6526314 Eberle et al. Feb 2003 B1
6527729 Turcott Mar 2003 B1
6537200 Leysieffer et al. Mar 2003 B2
6554761 Puria et al. Apr 2003 B1
6567700 Turcott et al. May 2003 B1
6574510 Von Arx et al. Jun 2003 B2
6575894 Leysieffer et al. Jun 2003 B2
6580946 Struble Jun 2003 B2
6584349 Sage et al. Jun 2003 B1
6584354 Mann et al. Jun 2003 B1
6585764 Wright et al. Jul 2003 B2
6589187 Dirnberger et al. Jul 2003 B1
6599242 Splett et al. Jul 2003 B1
6600949 Turcott Jul 2003 B1
6604000 Lu Aug 2003 B2
6607485 Bardy Aug 2003 B2
6609023 Fischell et al. Aug 2003 B1
6615083 Kupper Sep 2003 B2
6622049 Penner et al. Sep 2003 B2
6622050 Thompson Sep 2003 B2
6628985 Sweeney et al. Sep 2003 B2
6628989 Penner et al. Sep 2003 B1
6629922 Puria et al. Oct 2003 B1
6629951 Laufer et al. Oct 2003 B2
6638231 Govari et al. Oct 2003 B2
6643548 Mai et al. Nov 2003 B1
6644322 Webb Nov 2003 B2
6645145 Dreschel et al. Nov 2003 B1
6650939 Taepke, II et al. Nov 2003 B2
6654638 Sweeney Nov 2003 B1
6660034 Mandrusov et al. Dec 2003 B1
6671550 Iaizzo et al. Dec 2003 B2
6675049 Thompson et al. Jan 2004 B2
6682985 Yuzuriha et al. Jan 2004 B2
6697674 Leysieffer Feb 2004 B2
6699186 Wolinsky et al. Mar 2004 B1
6702847 DiCarlo Mar 2004 B2
6708061 Salo et al. Mar 2004 B2
6708065 Von Arx et al. Mar 2004 B2
6712772 Cohen et al. Mar 2004 B2
6719689 Munneke et al. Apr 2004 B2
6720709 Porat et al. Apr 2004 B2
6720887 Zunti Apr 2004 B1
6733447 Lai et al. May 2004 B2
6738671 Christophersom et al. May 2004 B2
6740076 Hoben et al. May 2004 B2
6741714 Jensen May 2004 B2
6743173 Penner et al. Jun 2004 B2
6754795 Chen et al. Jun 2004 B2
6763722 Fjield et al. Jul 2004 B2
6764446 Wolinsky et al. Jul 2004 B2
6772490 Toda Aug 2004 B2
6778859 Gaindorge Aug 2004 B2
6782810 Vilo Aug 2004 B2
6783499 Schwartz Aug 2004 B2
6792308 Corbucci Sep 2004 B2
6792311 Fox et al. Sep 2004 B2
6809507 Morgan et al. Oct 2004 B2
6823210 Eberle et al. Nov 2004 B2
6824512 Warkentin et al. Nov 2004 B2
6840956 Wolinsky et al. Jan 2005 B1
6855115 Fonseca et al. Feb 2005 B2
6859665 Ding et al. Feb 2005 B2
6865419 Mulligan et al. Mar 2005 B2
6868346 Larson et al. Mar 2005 B2
6869404 Schulhauser et al. Mar 2005 B2
6871088 Chinchoy Mar 2005 B2
6885889 Chinchoy Apr 2005 B2
6889086 Mass et al. May 2005 B2
6895265 Silver May 2005 B2
6907285 Denker et al. Jun 2005 B2
6910084 Augustijn et al. Jun 2005 B2
6915162 Noren et al. Jul 2005 B2
6926670 Rich et al. Aug 2005 B2
6937900 Pianca et al. Aug 2005 B1
6949075 Hatlesad et al. Sep 2005 B2
6961448 Nichols et al. Nov 2005 B2
6961617 Snell Nov 2005 B1
6970742 Mann et al. Nov 2005 B2
6978182 Mazar et al. Dec 2005 B2
6985773 Von Arx et al. Jan 2006 B2
6993393 Von Arx et al. Jan 2006 B2
7003350 Denker et al. Feb 2006 B2
7016721 Lee et al. Mar 2006 B2
7016739 Bange et al. Mar 2006 B2
7018336 Enegren et al. Mar 2006 B2
7024248 Penner et al. Apr 2006 B2
7027872 Thompson Apr 2006 B2
7033322 Silver Apr 2006 B2
7035684 Lee Apr 2006 B2
7047065 Kalgren et al. May 2006 B2
7060030 Von Arx et al. Jun 2006 B2
7061381 Forcier et al. Jun 2006 B2
7088254 Liebenow Aug 2006 B2
7107103 Schulman et al. Sep 2006 B2
7114502 Schulman et al. Oct 2006 B2
7115096 Siejko et al. Oct 2006 B2
7118531 Krill Oct 2006 B2
7123962 Siejko et al. Oct 2006 B2
7127290 Girouard et al. Oct 2006 B2
7130678 Ritscher et al. Oct 2006 B2
7134999 Brauker et al. Nov 2006 B2
7136703 Cappa et al. Nov 2006 B1
7160252 Cho et al. Jan 2007 B2
7176602 Schlenke Feb 2007 B2
7195594 Eigler et al. Mar 2007 B2
7198603 Penner et al. Apr 2007 B2
7200439 Zdeblick et al. Apr 2007 B2
7203545 Schmitt et al. Apr 2007 B2
7204798 Zdeblick et al. Apr 2007 B2
7212861 Park et al. May 2007 B1
7214189 Zdeblick May 2007 B2
7220232 Suorsa et al. May 2007 B2
7225030 Kroll et al. May 2007 B2
7228175 Jain et al. Jun 2007 B2
7236821 Cates Jun 2007 B2
7248923 Maile et al. Jul 2007 B2
7260429 Siejko et al. Aug 2007 B2
7273457 Penner Sep 2007 B2
7283874 Penner Oct 2007 B2
7294105 Islam Nov 2007 B1
7335161 Von Arx et al. Feb 2008 B2
7335169 Thompson et al. Feb 2008 B2
7392090 Sweeney et al. Jun 2008 B2
7399313 Brown et al. Jul 2008 B2
7425200 Brockway et al. Sep 2008 B2
7431699 Siejko et al. Oct 2008 B2
7452334 Gianchandani et al. Nov 2008 B2
7522962 Doron et al. Apr 2009 B1
7634318 Tran et al. Dec 2009 B2
20020023123 Madison Feb 2002 A1
20020042561 Schulman et al. Apr 2002 A1
20020045812 Ben-Haim et al. Apr 2002 A1
20020045836 Alkawwas Apr 2002 A1
20020147406 von Segesser Oct 2002 A1
20020151770 Noll, III et al. Oct 2002 A1
20020183628 Reich et al. Dec 2002 A1
20020188323 Penner et al. Dec 2002 A1
20030009204 Amundson et al. Jan 2003 A1
20030114897 Von Arx et al. Jun 2003 A1
20030136417 Fonseca et al. Jul 2003 A1
20030181794 Rini et al. Sep 2003 A1
20030191383 Ben-Haim et al. Oct 2003 A1
20040044393 Yarden et al. Mar 2004 A1
20040064133 Miller et al. Apr 2004 A1
20040077937 Yarden Apr 2004 A1
20040106954 Whitehurst et al. Jun 2004 A1
20040122484 Hatlestad et al. Jun 2004 A1
20040122486 Stahmann et al. Jun 2004 A1
20040127792 Siejko et al. Jul 2004 A1
20040138572 Thiagarajan Jul 2004 A1
20040152999 Cohen et al. Aug 2004 A1
20040172081 Wang Sep 2004 A1
20040204744 Penner Oct 2004 A1
20040230225 Penner et al. Nov 2004 A1
20040230249 Haefner Nov 2004 A1
20040260214 Echt et al. Dec 2004 A1
20050056539 Morgan et al. Mar 2005 A1
20050060186 Blowers et al. Mar 2005 A1
20050065815 Mazar et al. Mar 2005 A1
20050102002 Salo et al. May 2005 A1
20050131472 Ding et al. Jun 2005 A1
20050137490 Scheiner et al. Jun 2005 A1
20050149138 Min et al. Jul 2005 A1
20050149143 Libbus et al. Jul 2005 A1
20050154321 Wolinsky et al. Jul 2005 A1
20050159789 Brockway et al. Jul 2005 A1
20050182330 Brockway et al. Aug 2005 A1
20050187482 O'Brien et al. Aug 2005 A1
20050192637 Girouard et al. Sep 2005 A1
20050192844 Esler et al. Sep 2005 A1
20050197585 Brockway et al. Sep 2005 A1
20050215887 Ben-Haim et al. Sep 2005 A1
20050222631 Dalal et al. Oct 2005 A1
20050231374 Diem et al. Oct 2005 A1
20050242479 Petisce et al. Nov 2005 A1
20050288727 Penner Dec 2005 A1
20060009818 Von Arx et al. Jan 2006 A1
20060031378 Vallapureddy et al. Feb 2006 A1
20060064133 Von Arx et al. Mar 2006 A1
20060064134 Mazar et al. Mar 2006 A1
20060064142 Chavan et al. Mar 2006 A1
20060064143 Von Arx et al. Mar 2006 A1
20060085039 Hastings et al. Apr 2006 A1
20060085041 Hastings et al. Apr 2006 A1
20060085042 Hastings et al. Apr 2006 A1
20060089694 Zhang et al. Apr 2006 A1
20060136004 Cowan Jun 2006 A1
20060142819 Penner et al. Jun 2006 A1
20060149329 Penner Jul 2006 A1
20070043394 Zhang et al. Feb 2007 A1
20070049977 Von Arx et al. Mar 2007 A1
20070055184 Echt et al. Mar 2007 A1
20070060959 Salo et al. Mar 2007 A1
20070093875 Chavan et al. Apr 2007 A1
20070129765 Gilkerson et al. Jun 2007 A1
20070142727 Zhang et al. Jun 2007 A1
20070142728 Penner Jun 2007 A1
20080015421 Penner Jan 2008 A1
20080021289 Zhang et al. Jan 2008 A1
20080021333 Huelskamp Jan 2008 A1
20080021509 Mi et al. Jan 2008 A1
20080021510 Mi et al. Jan 2008 A1
20080021972 Huelskamp et al. Jan 2008 A1
20080058651 Shen et al. Mar 2008 A1
20080071178 Greenland et al. Mar 2008 A1
20080077440 Doron Mar 2008 A1
20100004718 Doron et al. Jan 2010 A1
20100049269 Tran Feb 2010 A1
Foreign Referenced Citations (52)
Number Date Country
3222349 Jan 1984 DE
0798016 Oct 1997 EP
0897690 Feb 1999 EP
0928598 Jul 1999 EP
1151719 Apr 2001 EP
1266606 Dec 2002 EP
1169085 Aug 2004 EP
WO 8303345 Oct 1983 WO
WO 9701986 Jan 1997 WO
WO 9732519 Sep 1997 WO
WO 9733513 Sep 1997 WO
WO 9735636 Oct 1997 WO
WO 9747236 Dec 1997 WO
WO 9826716 Jun 1998 WO
WO 9829030 Jul 1998 WO
WO 9917095 Apr 1999 WO
WO 9926530 Jun 1999 WO
WO 9934453 Jul 1999 WO
WO 9947205 Sep 1999 WO
WO 9955223 Nov 1999 WO
WO 9955225 Nov 1999 WO
WO 9959460 Nov 1999 WO
WO 9966988 Dec 1999 WO
WO 0016686 Mar 2000 WO
WO 0058744 Oct 2000 WO
WO 0128627 Apr 2001 WO
WO 0156467 Aug 2001 WO
WO 0174278 Oct 2001 WO
WO 0203347 Jan 2002 WO
WO 0232502 Apr 2002 WO
WO 03002243 Jan 2003 WO
WO 03068047 Aug 2003 WO
WO 03096889 Nov 2003 WO
WO 2004091719 Oct 2004 WO
WO 2005118056 Dec 2005 WO
WO 2006010010 Jan 2006 WO
WO 2006033812 Mar 2006 WO
WO 2006034183 Mar 2006 WO
WO 2006045073 Apr 2006 WO
WO 2006045074 Apr 2006 WO
WO 2006045075 Apr 2006 WO
WO 2006056857 Jun 2006 WO
WO 2006069215 Jun 2006 WO
WO 2007025163 Mar 2007 WO
WO 2007030474 Mar 2007 WO
WO 2007047287 Apr 2007 WO
WO 2007070794 Jun 2007 WO
WO 2008011570 Jan 2008 WO
WO 2008011577 Jan 2008 WO
WO 2008011592 Jan 2008 WO
WO 2008011593 Jan 2008 WO
WO 2008154145 Dec 2008 WO
Related Publications (1)
Number Date Country
20100094105 A1 Apr 2010 US
Continuations (4)
Number Date Country
Parent 10638405 Aug 2003 US
Child 12578376 US
Parent 09930455 Aug 2001 US
Child 10638405 US
Parent 09691887 Oct 2000 US
Child 10235968 US
Parent 09000553 Dec 1997 US
Child 09691887 US
Continuation in Parts (1)
Number Date Country
Parent 10235968 Sep 2002 US
Child 09930455 US